financetom
Business
financetom
/
Business
/
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement
May 8, 2024 11:33 AM

02:07 PM EDT, 05/08/2024 (MT Newswires) -- Merck ( MRK ) and AstraZeneca ( AZN ) sued Natco Pharma and Sandoz Group on Tuesday in the US District Court for the District of New Jersey, alleging that the defendants' generic copies of the plaintiffs' cancer drug Lynparza infringe their patents.

Natco Pharma and Sandoz did not immediately respond to MT Newswires' requests for comments.

Price: 129.57, Change: -0.81, Percent Change: -0.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved